OMEROS (OMER) Covered Calls

OMEROS covered calls Omeros Corporation is a clinical-stage biopharmaceutical Company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.

You can sell covered calls on OMEROS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for OMER (prices last updated Fri 4:16 PM ET):

OMEROS (OMER) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
15.86 +0.53 15.26 15.95 778K - 0.7B
Covered Calls For OMEROS (OMER)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 16 1.55 14.40 10.8% 136%
Jan 18 16 2.45 13.50 18.1% 71.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Omeros Corp. is a clinical stage biopharmaceutical company, which engages in the discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. Its products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. The company also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. Omeros was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.